Mr. Pyszczymuka is a proven commercial leader with extensive experience in pharmaceutical sales, market access, and revenue ...

The kits include two Narcan nasal spray devices with instructions for the proper administration and steps to be taken in the ...

The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Many recalls come as a result of product mislabeling, safety issues or contamination. Here are five recalls in particular ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

Milestone Pharmaceuticals (MIST) announced that it has received Notice of Allowance from the United States Patent and Trademark Office, or ...

Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...